Fig. 1From: Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter studyThe workflow of patient selection. NSCLC, non-small cell lung cancer; MPE, malignant pleural effusion; Chemo, chemotherapy; ICI, immune checkpoint inhibitorBack to article page